Epidemiology, implications and mechanisms underlying drug-induced weight gain in psychiatric patients
- 11 March 2003
- journal article
- review article
- Published by Elsevier in Journal of Psychiatric Research
- Vol. 37 (3) , 193-220
- https://doi.org/10.1016/s0022-3956(03)00018-9
Abstract
No abstract availableKeywords
This publication has 100 references indexed in Scilit:
- Insulin Resistance and Type 2 Diabetes Are Not Related to Resistin Expression in Human Fat Cells or Skeletal MuscleBiochemical and Biophysical Research Communications, 2001
- Fluoxetine improves insulin sensitivity in obese patients with non-insulin-dependent diabetes mellitus independently of weight lossInternational Journal of Obesity, 1997
- Drugs That Cause Weight GainObesity Research, 1995
- Sertraline and Relapse Prevention Training Following Treatment by Very‐Low‐Calorie Diet: A Controlled Clinical TrialObesity Research, 1995
- Efficacy and Safety of Long‐Term Fluoxetine Treatment of Obesity ‐ Maximizing SuccessObesity Research, 1995
- Serotoninergic Manipulation, Meal‐Induced Satiety and Eating Pattern: Effect of Fluoxetine in Obese Female SubjectsObesity Research, 1995
- Efficacy of felbamate in therapy for partial epilepsy in childrenThe Journal of Pediatrics, 1994
- Eating behaviour and depression before and after antidepressant treatment: a prospective, naturalistic studyJournal of Affective Disorders, 1994
- Chronic norepinephrine injection into the hypothalamic paraventricular nucleus produces hyperphagia and increased body weight in the ratPharmacology Biochemistry and Behavior, 1984
- Weight as a Correlate of Clinical Response to Psychotropic DrugsPsychosomatics, 1970